Coverage
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology
Immuno-Oncology coverage from APO|APE News.
Summit and Akeso Land HARMONi in The Lancet Oncology as Ivonescimab Beats Durvalumab on Survival in a China Biliary Tract Cancer Trial
China's NMPA Accepts Leads Biolabs' PD-L1/4-1BB Bispecific Opamtistomig for Review in Neuroendocrine Carcinoma
Merck and Moderna Report Positive Phase 3 Interim Readout for Individualized mRNA Therapy Intismeran in Resected Melanoma
FDA Grants Accelerated Approval to Replimune's Oncolytic Viral Therapy Tudriqev for Anti-PD-1 Refractory Melanoma
A Columbia Group Puts CAR T Cell TNF Upstream of the Macrophages That Drive Cytokine Release Syndrome
A Six-Protein Serum Profile Taken Before Infusion Separated Melanoma Patients Who Benefited From Unconditioned TIL Therapy
FDA Grants Fast Track Designation to Pliant's Oral Integrin Inhibitor PLN-101095 for Checkpoint-Refractory Solid Tumors